Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Bladder cancer

Low adherence to guidelines in non-muscle-invasive disease

Nature Reviews Urology volume 13, pages 570–571 (2016)Cite this article

Subjects

The American Urological Association, the Society of Urologic Oncology and the European Association of Urology have recently updated their guidelines for diagnosis and treatment of non-muscle-invasive bladder cancer. Several studies show that adherence to these guidelines is low, especially in North America. Physicians should try to comply with these guidelines to ensure optimal quality of care.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chang, S. S. et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J. Urol. http://dx.doi.org/10.1016/j.juro.2016.06.049 (2016).

  2. Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2016.05.041 (2016).

  3. Witjes, J. A. et al. Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS). BJU Int. 112, 742–750 (2013).

    Article  Google Scholar 

  4. Gontero, P. et al. Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. Urol. Int. 86, 19–24 (2011).

    Article  Google Scholar 

  5. Reek, C. et al. Quality of care in patients with newly diagnosed bladder cancer: a prospective assessment in northern Germany. Urologe A 52, 986–990 (2013).

    Article  CAS  Google Scholar 

  6. Siddins, M. T., Wong, V. V., Fitzgerald, J. T. & Bamberg, L. J. Challenges in non-muscle invasive bladder cancer: lessons from a regional review. ANZ J. Surg. 81, 889–894 (2011).

    Article  Google Scholar 

  7. Madeb, R. et al. Treatment of non-muscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors. Cancer 115, 2660–2670 (2009).

    Article  Google Scholar 

  8. Gotto, G. T., Shea-Budgell, M. A. & Dean Ruether, J. Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta. Can. Urol. Assoc. J. 10, 33–38 (2016).

    Article  Google Scholar 

  9. Huang, G. J., Hamilton, A. S., Lo, M., Stein, J. P. & Penson, D. F. Predictors of intravesical therapy for non-muscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project. J. Urol. 180, 520–524 (2008).

    Article  Google Scholar 

  10. Chamie, K. et al. Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer 117, 5392–5401 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bas W. G. van Rhijn is at the Department of Surgical Oncology (Urology), The Netherlands; and the Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121,1066 CX, Amsterdam, Caritas St. Josef Medical Centre, University of Regensburg, Landshuterstrasse 65, Regensburg 93053, Germany.,

    Bas W. G. van Rhijn

  2. and the Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Landshuterstrasse 65, Regensburg 93053, Germany.,

    Bas W. G. van Rhijn

  3. Maximilian Burger is at the Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Landshuterstrasse 65, Regensburg 93053, Germany.,

    Maximilian Burger

Authors
  1. Bas W. G. van Rhijn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maximilian Burger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bas W. G. van Rhijn.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van Rhijn, B., Burger, M. Low adherence to guidelines in non-muscle-invasive disease. Nat Rev Urol 13, 570–571 (2016). https://doi.org/10.1038/nrurol.2016.165

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.165

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer